Buscar resultados de ensayos clínicos
Richter Syndrome - 20 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders Condición:
Fecha: 2006-03-15 Intervenciones: Drug: laromustine |
Completed |
Nombre del estudio: Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL Condición: Leukemia Fecha: 2007-03-23 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (Btk) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia Condición:
|
Recruiting |
Nombre del estudio: Study of Pembrolizumab in Combination With Ublituximab and TGR-1202 in Patients With Relapsed-refractory CLL or Richter's Transformation Condición: Chronic Lymphocytic Leukemia Fecha: 2015-08-24 Intervenciones:
|
Completed |
Nombre del estudio: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT) Condición: Chronic Lymphocytic Leukemia Fecha: 2006-03-29 Intervenciones:
|
Withdrawn |
Nombre del estudio: Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation Condición:
|
Recruiting |
Nombre del estudio: Registry of the German CLL Study Group Condición:
|
Recruiting |
Nombre del estudio: Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL Condición:
|
Completed |
Nombre del estudio: Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL Condición:
|
Active, not recruiting |
Nombre del estudio: ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies Condición:
Intervenciones: |